Tuesday, September 30, 2008

Actavis to market BSV's anti-infective generic formulation in Europe, SA & Turkey

Bharat Serums and Vaccines Limited (BSV), one of the top ten Indian biopharmaceutical companies, has entered into an exclusive licensing , manufacturing and supply agreement with Actavis for marketing one of BSV's anti-infective generic formulations.

The details can be read here.

No comments: